Cargando…

BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis

BACKGROUND: Targeted therapies and immunotherapies are first-line treatments for patients with advanced melanoma. Serine–threonine protein kinase B-RAF (BRAF) and mitogen-activated protein kinase (MEK) inhibition leads to a 70% response rate in patients with advanced melanoma with a BRAF(V600E)(/K)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frazao, Alexandra, Rethacker, Louise, Jeudy, Géraldine, Colombo, Marina, Pasmant, Eric, Avril, Marie-Françoise, Toubert, Antoine, Moins-Teisserenc, Helene, Roelens, Marie, Dalac, Sophie, Maubec, Eve, Caignard, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Basic Tumor Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482503/ https://www.ncbi.nlm.nih.gov/pubmed/32912923 http://dx.doi.org/10.1136/jitc-2019-000275

Ejemplares similares

Specific Patterns of Blood ILCs in Metastatic Melanoma Patients and Their Modulations in Response to Immunotherapy
por: Rethacker, Louise, et al.
Publicado: (2021)

NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment
por: Frazao, Alexandra, et al.
Publicado: (2019)

Patient’s Natural Killer Cells in the Era of Targeted Therapies: Role for Tumor Killers
por: Messaoudene, Meriem, et al.
Publicado: (2017)

Phenotypic and Functional Characteristics of Blood Natural Killer Cells from Melanoma Patients at Different Clinical Stages
por: Fregni, Giulia, et al.
Publicado: (2013)

Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions
por: Russick, Jules, et al.
Publicado: (2020)

Skin immunization for effective treatment of multifocal melanoma refractory to PD1 blockade and Braf inhibitors
por: Hao, Xingxing, et al.
Publicado: (2021)

Determinants of response to daratumumab in Epstein-Barr virus-positive natural killer and T-cell lymphoma
por: Mustafa, Nurulhuda, et al.
Publicado: (2021)

Antagonistic anti-LILRB1 monoclonal antibody regulates antitumor functions of natural killer cells
por: Chen, Heyu, et al.
Publicado: (2020)

EpCAM-high liver cancer stem cells resist natural killer cell–mediated cytotoxicity by upregulating CEACAM1
por: Park, Dong Jun, et al.
Publicado: (2020)

Identification of neuroblastoma cell lines with uncommon TAZ(+)/mesenchymal stromal cell phenotype with strong suppressive activity on natural killer cells
por: Canzonetta, Claudia, et al.
Publicado: (2021)

ELK3 modulates the antitumor efficacy of natural killer cells against triple negative breast cancer by regulating mitochondrial dynamics
por: Park, Joo Dong, et al.
Publicado: (2022)

Medical debulking with BRAF/MEK inhibitors in aggressive BRAF-mutant craniopharyngioma
por: Di Stefano, Anna Luisa, et al.
Publicado: (2020)

Tumorigenicity and lysis by natural killers
Publicado: (1981)

When unity makes strength: Combinatorial NK cell-based immunotherapies against melanoma
por: Messaoudene, Meriem, et al.
Publicado: (2014)

Correction: BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis
Publicado: (2021)

CXCR6 deficiency impairs cancer vaccine efficacy and CD8(+) resident memory T-cell recruitment in head and neck and lung tumors
por: Karaki, Soumaya, et al.
Publicado: (2021)

Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) neutralization counteracts T cell immune evasion in breast cancer
por: Travelli, Cristina, et al.
Publicado: (2023)

Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy
por: Hubert, Pascale, et al.
Publicado: (2021)

CXCR4-Related Increase of Circulating Human Lymphoid Progenitors after Allogeneic Hematopoietic Stem Cell Transplantation
por: Glauzy, Salomé, et al.
Publicado: (2014)

PPARγ activation modulates the balance of peritoneal macrophage populations to suppress ovarian tumor growth and tumor-induced immunosuppression
por: Prat, Mélissa, et al.
Publicado: (2023)

Characterization of the Microenvironment in Positive and Negative Sentinel Lymph Nodes from Melanoma Patients
por: Messaoudene, Meriem, et al.
Publicado: (2015)

Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study
por: Rea, Delphine, et al.
Publicado: (2017)

NK cells sense tumors, course of disease and treatments: Consequences for NK-based therapies
por: Fregni, Giulia, et al.
Publicado: (2012)

Severe Altered Immune Status After Burn Injury Is Associated With Bacterial Infection and Septic Shock
por: Moins-Teisserenc, Hélène, et al.
Publicado: (2021)

THU504 Is Carney Complex A Predisposing Syndrome For Breast Cancer? Prospective Study Of 50 Women
por: Vaduva, Patricia, et al.
Publicado: (2023)

Identification of HPV16 E1 and E2-specific T cells in the oropharyngeal cancer tumor microenvironment
por: McInnis, Christine, et al.
Publicado: (2023)

Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy
por: Mortensen, Rasmus Erik Johansson, et al.
Publicado: (2023)

Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes
por: Solvay, Marie, et al.
Publicado: (2023)

Intrahepatic CD69(+)Vδ1 T cells re-circulate in the blood of patients with metastatic colorectal cancer and limit tumor progression
por: Bruni, Elena, et al.
Publicado: (2022)

Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells
por: Weis-Banke, Stine Emilie, et al.
Publicado: (2022)

Innate lymphoid cells: NK and cytotoxic ILC3 subsets infiltrate metastatic breast cancer lymph nodes
por: Rethacker, Louise, et al.
Publicado: (2022)

Chemoradiation triggers antitumor Th1 and tissue resident memory-polarized immune responses to improve immune checkpoint inhibitors therapy
por: Lauret Marie Joseph, Elodie, et al.
Publicado: (2021)

BIOL-05. MAPK PATHWAY INHIBITION SENSITIZES TO IMMUNOTHERAPY IN BRAF-MUTANT GLIOMAS
por: Park, Jong-Whi, et al.
Publicado: (2021)

Underground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer Cells
por: Dulphy, Nicolas, et al.
Publicado: (2016)

Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients
por: Farge, Dominique, et al.
Publicado: (2017)

Fractalkine Expression Induces Endothelial Progenitor Cell Lysis by Natural Killer Cells
por: Todorova, Dilyana, et al.
Publicado: (2011)

Prospective Study of the Evolution of Blood Lymphoid Immune Parameters during Dacarbazine Chemotherapy in Metastatic and Locally Advanced Melanoma Patients
por: Mignot, Grégoire, et al.
Publicado: (2014)

Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites
por: Jennings, VA, et al.
Publicado: (2014)

CD47/SIRPα blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy
por: Wang, Hongfei, et al.
Publicado: (2020)

Regulation of tumor growth by leukocyte-specific protein 1 in T cells
por: Kwon, Riri, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_am957gmbedpm7cp9u4jkh8eiot